Skip to content

CLYM - Climb Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Climb Bio Inc

CLYM · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CLYMClimb Bio Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $18.14
52-wk low: $1.54
Prev close: $10.53
Mkt cap: $995.9M
Beta: 0.08
P/B: 4.2x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$168.3M

CI
Citadel
Ken Griffin · Q2 2026 13F
$16.9M
position
MI
Millennium

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $996M

Valuation

P/B4.17

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CLYM
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $995.95M
Beta: 0.08

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-27.1%

Israel Englander · Q2 2026 13F

$11.8M

position

MW

Marshall Wace

Q1 2026 13F

$5.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CLYM

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.20

-$0.23 to -$0.16

Revenue expected

$0.00

15 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

-27.1%

ROA-18.4%

Growth

Beta0.08